menu
    • menu

    Company profile for Philogen

    NEW Drugs in Dev: 20
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders. Angiogenesis, i.e. the formation of new blood vessels, is a characteristic feature of many severe pathologies such as cancer, rheumatoid arthritis and age-related macular degeneration. The company has been a pioneer in the isolation, enginee...
    Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders. Angiogenesis, i.e. the formation of new blood vessels, is a characteristic feature of many severe pathologies such as cancer, rheumatoid arthritis and age-related macular degeneration. The company has been a pioneer in the isolation, engineering and clinical development of lead products capable of targeting angiogenesis in-vivo and has been the first in the world to demonstrate that human monoclonal antibodies, specific for a marker of angiogenesis,etc.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PhilogenItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Via Bellaria, 35, 53018 Sovicille (SI)
    Telephone
    Telephone
    (+39) 0577.1781.6
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.philogen.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/philogen
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AACR Annual meeting

    AACR Annual meeting

    Not Confirmed

    envelop Contact Supplier

    AACR Annual meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sun Pharma Advances New Phase III Study In Soft Tissue Sarcoma
    Sun Pharma Advances New Phase III Study In Soft Tissue Sarcoma

    07 Apr 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/biotech/sun-pharma-flags-mixed-fibromun-trial-results-advances-new-phase-iii-study-in-soft-tissue-sarcoma-19544

    INDPHARMAPOST
    07 Apr 2026
    Share Share
    Philogen Updates On Fibromun Clinical Study Developments
    Philogen Updates On Fibromun Clinical Study Developments

    13 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/clinical-trials/philogen-updates-on-fibromun-clinical-study-developments-18225

    INDPHARMAPOST
    13 Nov 2025
    Share Share
    Philogen withdraws Nidlegy marketing application in EU
    Philogen withdraws Nidlegy marketing application in EU

    26 Jun 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/philogen-withdraws-marketing-authorization-application-for-nidlegy-in-eu-17312

    INDPHARMAPOST
    26 Jun 2025
    Share Share
    Sun Pharma, Philogen Enter Exclusive Licensing Pact For Firbomun
    Sun Pharma, Philogen Enter Exclusive Licensing Pact For Firbomun

    30 Sep 2024

    // Viswanath Pilla ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-philogen-enter-exclusive-licensing-pact-for-commercialisation-of-specialty-cancer-drug-firbomun/articleshow/113838280.cms

    Viswanath Pilla ECONOMICTIMES
    30 Sep 2024
    Share Share
    Philogen, Sun Pharma announce EMA validates Marketing Authorization Application
    Philogen, Sun Pharma announce EMA validates Marketing Authorization Application

    04 Jul 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=170120&sid=2

    PHARMABIZ
    04 Jul 2024
    Share Share
    Philogen and Sun Pharma seek EMA approval for melanoma therapy
    Philogen and Sun Pharma seek EMA approval for melanoma therapy

    04 Jun 2024

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/sun-pharma-philogen-melanoma-therapy/

    PHARMACEUTICAL TECHNOLOGY
    04 Jun 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search